ProTrials Research, Inc. is a full-service clinical research organization (CRO) founded in 1996 and headquartered in Silicon Valley, California. As a women-owned business, ProTrials partners with pharmaceutical, biotechnology, and medical device companies to deliver high-quality clinical development services across all phases of research, from early Phase I through Phase IV. With a global operational footprint, ProTrials provides comprehensive capabilities including project management, clinical operations, site management and monitoring, data management, quality assurance, and regulatory support. The company has successfully completed more than 775 clinical projects across 17,500+ sites and 210,000+ subjects worldwide. ProTrials offers deep therapeutic expertise in ophthalmology. Known for its quality-driven approach, experienced teams, and strong site relationships, ProTrials is recognized as a trusted partner committed to delivering efficient, flexible, and high-quality clinical tr
ProMed Pharma LLC
ProMed Pharma specializes in hot melt extrusion and injection molding of drug-loaded polymers, applying this expertise to the cGMP manufacture of ophthalmic dosage forms and drug-device combination products. We partner with both early-stage and established pharmaceutical companies, using robust and scalable processes to enable controlled release of active pharmaceutical ingredients (APIs) across a range of polymer systems. From early feasibility through clinical supply and commercial production, ProMed supports the development of controlled-release therapies for intravitreal and intracameral implants, punctal plugs, ocular rings, and related ophthalmic delivery systems. Our facilities are equipped to handle a broad spectrum of potent compounds, including prostaglandins, tyrosine kinase inhibitors (TKIs), antibiotics, and steroids. For more information, please visit www.promedpharmallc.com
PREMIER DENTAL PRODUCTS
Premier Dental® is dedicated to delivering Inspired Solutions for Daily Dentistry® worldwide. For over 100 years, dental professionals have trusted Premier for innovative, standard-setting products that improve procedures, practices, and patient outcomes. Inspired by the work clinicians do every day, we are committed to providing effective, efficient solutions.
PozeSCAF Discovery Solutions
PozeSCAF is a preclinical drug discovery company, that leverages an in-house generative AI-based discovery platform – AxDrug integrated with computational chemistry tools and synthetic chemistry lab to create best-in-class lead candidates for our clients.
PHC Corporation of North America
PHC Corporation of North America located in Wood Dale, IL, is a leader in laboratory equipment for the biopharmaceutical, life sciences, academic, healthcare and government markets. Product lines under the PHCbi brand include the space saving and energy efficient VIP® ECO and TwinGuard® ultra-low temperature freezers, cryogenic and biomedical freezers, pharmacy and high-performance refrigerators, cell culture CO2 and multigas incubators, Drosophila/plant growth chambers, and cell and gene therapy solutions. PHC Corporation of North America is a subsidiary of PHC Holdings Corporation, Tokyo, Japan, which is a global healthcare company that develops, manufactures, sells, and services solutions across diabetes management, healthcare solutions, diagnostics and life sciences. | PHC Corporation of North America (PHCNA), headquartered in Wood Dale, IL, is a supplier of PHCbi life sciences laboratory solutions. PHCNA empowers scientific advancement by providing technologies that protect and support critical research. PHCbi solutions provided by PHCNA are trusted by researchers across the United States, Canada, and select countries in Latin America for their reliability and innovation. PHCbi is a global leader in life science laboratory equipment, offering solutions that enhance every stage of the research workflow—from sample preservation to cell culture to regenerative medicine. PHCNA is a proud subsidiary of PHC Holdings Corporation (TSE 6523), based in Tokyo, Japan — a global healthcare enterprise that develops, manufactures, distributes, and services solutions across diabetes management, healthcare solutions, diagnostics and life sciences. | PHC Corporation of North America (PHCNA) is headquartered in Wood Dale, IL and manufactures and markets PHCbi brand laboratory equipment. PHCNA is a subsidiary of PHC Holdings Corporation of Tokyo, Japan, a global diversified diagnostics, life sciences, and medical device company. Our goal is to support the work of our customers and to improve the health and well-being of people around the world. For more than 50 years, PHCNA has met the needs of pharmaceutical, biotechnology, hospital/clinical and industrial customers, offering a unique perspective on scientific research. We play a critical role in global product development for a wide variety of applications and have established a reputation as a manufacturer of high-quality and innovative medical, diagnostic, and laboratory equipment. Our products are marketed as the PHCbi brand, and our product lines include CO2 and multigas incubators, ultra-low temperature freezers, cryogenic and biomedical freezers, and high-performance refrigerators | PHC Corporation of North America, located in Wood Dale, IL, is a leader in laboratory equipment for the biopharmaceutical, life sciences, academic, healthcare and government markets. Product lines under the PHCbi brand include the space saving and energy efficient VIP® ECO and TwinGuard® ultra-low temperature freezers, cryogenic and biomedical freezers, pharmacy and high-performance refrigerators, cell culture CO2 and multigas incubators, and Drosophila/plant growth chambers. PHC Corporation of North America is a subsidiary of PHC Holdings Corporation, Tokyo, Japan, which is a global healthcare company that develops, manufactures, sells, and services solutions across diabetes management, healthcare solutions, diagnostics and life sciences.
Pfizer
About Pfizer: Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com.In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer. | About Pfizer: Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. | At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
Pfizer Oncology
At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecifics and other immunotherapies. We are focused on delivering transformative therapies in some of the world’s most common cancers, including breast cancer, genitourinary cancer and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological and thoracic cancers, which includes lung cancer. Driven by science, we are committed to accelerating breakthroughs to extend and improve patients’ lives.
Personalis, Inc
Personalis is transforming the active management of cancer through more personalized testing. Our assays combine tumor-and-normal profiling with proprietary algorithms to deliver the most advanced insights, even as cancer evolves over time. With our industry-leading products, you can detect recurrence at the earliest timepoints, confidently select therapies based on ultra-comprehensive genomic profiling, and enhance your biomarker strategy for drug development. Join us as we redefine precision oncology.
PepGel Cellular Biomimicry
At PepGel, we drive advances in cancer research and regenerative medicine built on next-generation synthetic hydrogel technologies. Unlike conventional 2D cultures or legacy artificial “3D” aggregates, Our innovative PGmatrix technology faithfully mimics the human extracellular matrix, unlocking new possibilities in cancer research and regenerative medicine through tumor organoids, transformative stem cell innovations and tissue regeneration. Our advanced solutions also propel progress in drug discovery, disease modeling, and in vivo drug delivery, accelerating the path from research to therapy. The PepGel portfolio encompasses four core product lines: PGmatrix 3D Cells, PGmatrix Stem-X, PGmatrix Bioink, and PGmatrix Injection. Complementing these product lines, we also provide custom hydrogel formulations, hiPSC-derived somatic cells, and advanced 3D tumor and organoid models for precise drug efficacy and toxicity testing and regenerative medicine. We move health forward, inspired by you.